Low-carb, low-fat cannabis is the gift that keeps on giving:
Britain's GW Pharmaceuticals Plc said Tuesday it plans to start human trials of an experimental treatment for obesity derived from cannabis.
Cannabis is commonly associated with stimulating hunger. Several other companies, including Sanofi-Aventis with Acomplia, are working on new drugs that try to switch off the brain circuits that make people hungry when they smoke it.
GW Pharma, however, says it has derived a treatment from cannabis itself that could help suppress hunger.